About the Journal
The International Journal of Molecular Oncology (IJMO) is a peer-reviewed scientific journal dedicated to the advancement of research in molecular oncology. The journal provides an international platform for the dissemination of original research, reviews, and scholarly articles that explore the molecular basis of cancer and its translation into clinical practice.
IJMO is committed to publishing high-quality, ethically sound, and scientifically rigorous research that enhances the understanding of cancer biology and supports the development of innovative diagnostic and therapeutic strategies.
Journal Overview
The International Journal of Molecular Oncology focuses on the molecular and cellular mechanisms that drive cancer development, progression, and therapeutic response. By integrating basic science, translational research, and clinical insights, IJMO aims to bridge the gap between laboratory discoveries and patient-centered oncology care.
The journal encourages interdisciplinary research and welcomes contributions from researchers, clinicians, and industry professionals across the globe.
Aims and Objectives
The primary objectives of IJMO are to:
-
Promote excellence in molecular oncology research
-
Facilitate global exchange of scientific knowledge
-
Support translational research that impacts clinical oncology
-
Encourage innovation in cancer diagnostics and therapeutics
-
Uphold the highest standards of scientific integrity and publication ethics
Scope of the Journal
IJMO publishes research covering a broad spectrum of molecular oncology, including but not limited to:
-
Cancer genomics and epigenetics
-
Molecular signaling pathways in cancer
-
Tumor biology and microenvironment
-
Molecular diagnostics and biomarkers
-
Targeted and personalized cancer therapies
-
Cancer immunology and immunotherapy
-
Drug resistance and molecular pharmacology
-
Translational and clinical molecular oncology
-
Bioinformatics and systems oncology
